SCHEMBL7745801

SCHEMBL7745801

CC(C)CCn1c(CN2C(=O)C(CC(=O)NC(c3ccccc3)c3ccccc3)c3ccccc32)nc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 3/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 2/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
CDC25A P30304 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745735 0.88 TSHR (0.49) TSHRMAPK1NPSR1ALDH1A1CYP1A2
SCHEMBL7745704 0.87 LMNA (0.43) TSHRMAPK1HTTLMNAGAA
SCHEMBL7746011 0.85 GAA (0.49) TSHRMAPK1ALDH1A1LMNAGAA
SCHEMBL7741006 0.84 TSHR (0.47) TSHRMAPK1NPSR1ALDH1A1CYP1A2
SCHEMBL7741104 0.80 TSHR (0.55) TSHRMAPK1NPSR1ALDH1A1HTT
SCHEMBL2880216 0.71 TSHR (0.48) TSHRMAPK1ALDH1A1CYP3A4LMNA
SCHEMBL7745839 0.71 TSHR (0.52) TSHRMAPK1NPSR1ALDH1A1HTT
SCHEMBL7740725 0.69 TSHR (0.45) TSHRMAPK1NPSR1ALDH1A1CYP1A2
SCHEMBL7745697 0.69 TSHR (0.64) TSHRMAPK1NPSR1ALDH1A1CYP1A2
SCHEMBL7740562 0.69 TSHR (0.57) TSHRMAPK1NPSR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed